Gilead, DOJ Allowed To Redact Remaining Docs In Patent Row

By Leslie A. Pappas · April 4, 2023, 5:02 PM EDT

The federal government and Gilead Sciences Inc. got approval from a federal judge Tuesday to redact a limited number of documents after making public dozens of previously sealed filings in response...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

The United States of America v. Gilead Sciences, Inc. et al

Case Number

Court

Delaware

Nature of Suit

Patent

Date Filed

November 06, 2019

Recent Articles By Leslie

September 10, 2024
Philips Balks At Dentons' Request To Exit IP Case
September 05, 2024
Lupin Infringes Exeltis Contraceptive Patents, Judge Finds
August 15, 2024
Del. Chancery OKs $175M Judgment Against Insys Founder
August 01, 2024
Medtronic Still Faces Chancery Claim In Fortis' InPen Suit
July 12, 2024
Chancery Approves $19.5M Convey-TPG Settlement
June 25, 2024
Chancery OKs $71M Premier Deal, $14M Four-Firm Fee
June 21, 2024
Ex-CEO Found Liable For $1 Now Seeks Atty Fees For Del. Suit
June 12, 2024
Directors Of Defunct Med Tech SPAC Seek Toss Of Del. Suit
May 21, 2024
SPAC Investor's Suit Changes Came Too Late, Chancery Rules
May 17, 2024
EndoStim Emerges From Delaware Insolvency Proceeding